COVID-19検出PoCキット市場：サンプルハンドリング、サンプルタイプ、エンドユース別-2025-2030年世界予測

COVID-19検出PoCキット市場は、2023年に33億9,000万米ドルと評価され、2024年には36億1,000万米ドルに達すると予測され、CAGR 6.70％で成長し、2030年には53億4,000万米ドルに達すると予測されています。

COVID-19検出PoC（Point-of-Care）キットの範囲と定義は、従来の検査室環境以外での迅速で利用しやすい検査を可能にする役割を包含しています。これらのキットは、COVID-19症例の迅速な同定と隔離に不可欠であり、空港、職場、医療施設などの多様な環境におけるリアルタイムの意思決定を促進します。適用範囲は、遠隔地の恵まれない地域から都市中心部まで広がり、公衆衛生への対応を強化し、トランスミッションを減少させる。最終用途の市場には、ヘルスケア施設、公衆衛生機関、民間企業、旅行・教育分野が含まれ、それぞれがアウトブレイクを管理し安全を確保するための効率的な検査ソリューションを求めています。

市場成長は、迅速検査ソリューションに対する継続的な需要、新種の出現、医療インフラの改善に対する世界の焦点の影響を受けています。重要な機会は、検査精度と効率を高めることができるAI主導のデータ分析のような革新的な技術の統合にあります。遠隔医療の台頭は、PoC検査を家庭環境まで拡大し、検査へのアクセス性を高める可能性も示しています。しかし、市場の進展は、サプライチェーンの混乱、規制上のハードル、地域によって異なる政府認可といった物流上の課題によって阻まれています。さらに、競合情勢は混雑しており、多数の企業が市場シェア獲得にしのぎを削っています。

市場機会を生かすためには、企業は高感度で特異性の高い検査の開拓、費用対効果の最適化、使いやすい設計の確保に注力すべきです。デジタル統合のためのハイテク企業との提携や、分散製造のためのパートナーシップも、価値ある戦略となりうる。複数の病原体を同時に検出するマルチプレックス検査の研究開発への投資は、有望なイノベーション分野です。同市場は、技術の進歩や進化するヘルスケア・ニーズに後押しされてダイナミックな性質を示し、企業は変化に機敏に対応し続けることが求められます。長期的な成功は、需要の変化への適応力と、製品の品質とサプライチェーンの強靭性を維持しながら厳しい規制基準を満たす能力にかかっています。

市場力学：急速に進化するCOVID-19検出PoCキット市場の主要市場インサイトを公開

COVID-19検出PoCキット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • PoC試験へのパラダイムシフト
  • COVID症例の増加に伴うCOVID-19検出に対する政府支援の増加
  • 新しいPoC診断機器の急速な発売
• 市場抑制要因
  • 訓練を受けた臨床スタッフがいないため、分析装置のメンテナンスが複雑であること
• 市場機会
  • COVID-19に対する規制当局および政府による製品認可の増加
  • PoC診断検査開発のための民間および公的機関による資金調達と投資の増加
• 市場の課題
  • PoC検査の副作用に関する懸念

ポーターの5つの力：COVID-19検出PoCキット市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：COVID-19検出PoCキット市場における外部からの影響の把握

外部マクロ環境要因は、COVID-19検出PoCキット市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析COVID-19検出PoCキット市場における競合情勢の把握

COVID-19検出PoCキット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスCOVID-19検出PoCキット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、COVID-19検出PoCキット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨COVID-19検出PoCキット市場における成功への道筋を描く

COVID-19検出PoCキット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • PoCテストへのパラダイムシフト
    • COVID-19の症例増加に伴い、 COVID-19検出に対する政府の支援が増加
    • 新しいPoC診断機器の迅速な発売
  • 抑制要因
    • 訓練を受けていない臨床スタッフによる分析装置の複雑なメンテナンス
  • 機会
    • 規制当局による製品承認と政府によるCOVID-19検査の増加
    • PoC診断テストの開発に対する民間および公的機関による資金と投資の増加
  • 課題
    • PoCテストの悪影響に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 COVID-19検出PoCキット市場サンプル処理

• RNA抽出システム
  • ポイントオブケア検査装置
  • 迅速検査キット
  • RT-PCR検査

第7章 COVID-19検出PoCキット市場サンプルタイプ別

• 鼻腔スワブ
• 鼻咽頭スワブ
• 口腔咽頭スワブ
• 唾液

第8章 COVID-19検出PoCキット市場：最終用途別

• 診断センターとクリニック
• ホームケア
• 病院

第9章 南北アメリカのCOVID-19検出PoCキット市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のCOVID-19検出PoCキット市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのCOVID-19検出PoCキット市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Aurora Biomed Inc.
• Becton Dickinson and company
• BGI Group
• BioFire Diagnostics
• bioMerieux SA
• Cerba HealthCare S.A.S. by EQT
• Co-Diagnostics, Inc.
• Convergent Technologies GmbH & Co. KG
• Cue health Inc.
• DiaSorin S.p.A.
• Drummond Scientific Company
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• Mylab Discovery Solutions Pvt. Ltd.
• Quest Diagnostics
• Quidel Corporation
• SD Biosensor Inc.
• Seegene, Inc
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. COVID-19 DETECTION POC KITS MARKET RESEARCH PROCESS
• FIGURE 2. COVID-19 DETECTION POC KITS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. COVID-19 DETECTION POC KITS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. COVID-19 DETECTION POC KITS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COVID-19 DETECTION POC KITS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COVID-19 DETECTION POC KITS MARKET DYNAMICS
• TABLE 7. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY POINT-OF-CARE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RAPID TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RT-PCR TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASAL SWABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 36. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 37. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 58. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 59. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 62. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 63. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 131. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 132. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 146. POLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 147. POLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 148. POLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. QATAR COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 151. QATAR COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 152. QATAR COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE HANDLING, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY RNA EXTRACTION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. COVID-19 DETECTION POC KITS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. COVID-19 DETECTION POC KITS MARKET, FPNV POSITIONING MATRIX, 2023

The COVID-19 Detection PoC Kits Market was valued at USD 3.39 billion in 2023, expected to reach USD 3.61 billion in 2024, and is projected to grow at a CAGR of 6.70%, to USD 5.34 billion by 2030.

The scope and definition of COVID-19 Detection PoC (Point-of-Care) Kits encompass their role in enabling rapid, accessible testing outside traditional laboratory settings. These kits are essential for quick identification and isolation of COVID-19 cases, facilitating real-time decision-making in diverse environments such as airports, workplaces, and medical facilities. The application scope spans from remote, under-resourced areas to urban centers, enhancing public health responses and reducing transmission. End-use markets include healthcare facilities, public health organizations, private corporations, and travel and education sectors, each seeking efficient testing solutions for managing outbreaks and ensuring safety.

Market growth is influenced by the ongoing demand for rapid testing solutions, the emergence of new variants, and the global focus on health infrastructure improvement. A key opportunity lies in the integration of innovative technologies like AI-driven data analysis, which can enhance test accuracy and efficiency. The rise of telemedicine also presents potential for expanding PoC testing to home settings, increasing test accessibility. However, market advancement is challenged by logistical issues like supply chain disruptions, regulatory hurdles, and varying governmental approvals across regions. Furthermore, the competitive landscape is crowded, with numerous players striving for market share.

To capitalize on market opportunities, firms should focus on developing highly sensitive and specific tests, optimizing cost-effectiveness, and ensuring easy-to-use designs. Collaborations with tech companies for digital integration and partnerships for distributed manufacturing can be valuable strategies. Investing in R&D for multiplex testing-detecting multiple pathogens simultaneously-presents a promising innovation area. The market exhibits a dynamic nature, fueled by technological advancements and evolving healthcare needs, requiring businesses to remain agile and responsive to changes. Long-term success will depend on adaptability to shifts in demand and the ability to meet stringent regulatory standards while maintaining product quality and supply chain resilience.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COVID-19 Detection PoC Kits Market

The COVID-19 Detection PoC Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Paradigm shift towards PoC testing
  • Rising government support for COVID-19 detection owing to rising cases of COVID
  • Rapid launch of new PoC diagnostic devices
• Market Restraints
  • Complex maintenance of the analyzers owing to non trained clinical staff
• Market Opportunities
  • Increasing product approval by regulatory bodies and government testing for COVID-19
  • Increasing funding and investments by private and public organizations for the development of PoC diagnostic tests
• Market Challenges
  • Concerns associated with adverse effect of PoC testing

Porter's Five Forces: A Strategic Tool for Navigating the COVID-19 Detection PoC Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COVID-19 Detection PoC Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COVID-19 Detection PoC Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COVID-19 Detection PoC Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COVID-19 Detection PoC Kits Market

A detailed market share analysis in the COVID-19 Detection PoC Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COVID-19 Detection PoC Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COVID-19 Detection PoC Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COVID-19 Detection PoC Kits Market

A strategic analysis of the COVID-19 Detection PoC Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COVID-19 Detection PoC Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aurora Biomed Inc., Becton Dickinson and company, BGI Group, BioFire Diagnostics, bioMerieux SA, Cerba HealthCare S.A.S. by EQT, Co-Diagnostics, Inc., Convergent Technologies GmbH & Co. KG, Cue health Inc., DiaSorin S.p.A., Drummond Scientific Company, F. Hoffmann-La Roche AG, Hologic, Inc., Mylab Discovery Solutions Pvt. Ltd., Quest Diagnostics, Quidel Corporation, SD Biosensor Inc., Seegene, Inc, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the COVID-19 Detection PoC Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Sample Handling, market is studied across RNA Extraction Systems. The RNA Extraction Systems is further studied across Point-Of-Care Testing Devices, Rapid Testing Kits, and RT-PCR testing.
• Based on Sample Type, market is studied across Nasal Swabs, Nasopharyngeal Swab, Oropharyngeal Swab, and Saliva.
• Based on End-Use, market is studied across Diagnostic Centers & Clinics, Home Care, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Paradigm shift towards PoC testing
    • 5.1.1.2. Rising government support for COVID-19 detection owing to rising cases of COVID
    • 5.1.1.3. Rapid launch of new PoC diagnostic devices
  • 5.1.2. Restraints
    • 5.1.2.1. Complex maintenance of the analyzers owing to non trained clinical staff
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing product approval by regulatory bodies and government testing for COVID-19
    • 5.1.3.2. Increasing funding and investments by private and public organizations for the development of PoC diagnostic tests
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with adverse effect of PoC testing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. COVID-19 Detection PoC Kits Market, by Sample Handling

• 6.1. Introduction
• 6.2. RNA Extraction Systems
  • 6.2.1. Point-Of-Care Testing Devices
  • 6.2.2. Rapid Testing Kits
  • 6.2.3. RT-PCR testing

7. COVID-19 Detection PoC Kits Market, by Sample Type

• 7.1. Introduction
• 7.2. Nasal Swabs
• 7.3. Nasopharyngeal Swab
• 7.4. Oropharyngeal Swab
• 7.5. Saliva

8. COVID-19 Detection PoC Kits Market, by End-Use

• 8.1. Introduction
• 8.2. Diagnostic Centers & Clinics
• 8.3. Home Care
• 8.4. Hospitals

9. Americas COVID-19 Detection PoC Kits Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific COVID-19 Detection PoC Kits Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa COVID-19 Detection PoC Kits Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aurora Biomed Inc.
• 3. Becton Dickinson and company
• 4. BGI Group
• 5. BioFire Diagnostics
• 6. bioMerieux SA
• 7. Cerba HealthCare S.A.S. by EQT
• 8. Co-Diagnostics, Inc.
• 9. Convergent Technologies GmbH & Co. KG
• 10. Cue health Inc.
• 11. DiaSorin S.p.A.
• 12. Drummond Scientific Company
• 13. F. Hoffmann-La Roche AG
• 14. Hologic, Inc.
• 15. Mylab Discovery Solutions Pvt. Ltd.
• 16. Quest Diagnostics
• 17. Quidel Corporation
• 18. SD Biosensor Inc.
• 19. Seegene, Inc
• 20. Thermo Fisher Scientific, Inc.